Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of prostate cancer. Metastatic means the cancer ...

The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Dr. Bruce Montgomery, a UW Medicine oncologist, hopes that patients won't see these numbers and just throw up their hands in fear or resignation.

Scientists at the University of Michigan Rogel Cancer Center have found a promising new way to fight one of the most ...

Prostate cancer is the second-leading cause of cancer deaths among men in the United States and the rate of men diagnosed with advanced disease has been growing in recent years. 1 Veracyte estimates ...

"Prostate cancer is a worldwide problem. It is the most common cancer in men, with clear racial disparities,” said researcher ...

Experts developed consensus recommendations through the modified Delphi process for metastatic prostate cancer management ...

(UroToday.com) The American Urological Association's 2025 Annual Meeting, in Las Vegas, Nevada, was host to the Plenary Session on Saturday. Dr. Samir Taneja gave the State-of-the-Art Lecture titled: ...

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

The treatment of metastatic castration-resistant prostate cancer ... With appropriate treatment, people with this advanced ...